Announcements Trials

Browse Landscape

Sponsor

Conditions

Lung Neoplasms 15 Carcinoma, Non-Small-Cell Lung 10 Ovarian Neoplasms 8 Carcinoma, Hepatocellular 7 Urinary Bladder Neoplasms 6 Fallopian Tube Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Melanoma 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Endometrial Neoplasms 4 Nasopharyngeal Carcinoma 3 Mouth Neoplasms 3 Glioblastoma 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Oropharyngeal Neoplasms 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell 2

Interventions

Nivolumab 2 trametinib 1 selpercatinib 1 lenvatinib 1 fludarabine 1 dabrafenib 1 cemiplimab 1 aldesleukin 1 Radiotherapy, Intensity-Modulated 1 Ipilimumab 1 Cyclophosphamide 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Immunoglobulin G × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡